Outpatient parenteral antimicrobial therapy
- PMID: 24421785
- PMCID: PMC3630020
- DOI: 10.1155/2013/205910
Outpatient parenteral antimicrobial therapy
Similar articles
-
Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.J Clin Pharm Ther. 2018 Apr;43(2):220-223. doi: 10.1111/jcpt.12635. Epub 2017 Oct 13. J Clin Pharm Ther. 2018. PMID: 29030859
-
Outpatient parenteral antimicrobial therapy in pediatrics: an opportunity to expand antimicrobial stewardship.Infect Control Hosp Epidemiol. 2015 Feb;36(2):222-4. doi: 10.1017/ice.2014.27. Infect Control Hosp Epidemiol. 2015. PMID: 25633007
-
Outpatient parenteral antimicrobial therapy: experience in a large teaching hospital.J Infect. 1997 Jul;35(1):73-6. doi: 10.1016/s0163-4453(97)91073-2. J Infect. 1997. PMID: 9279728
-
Can intravenous antifungal therapy be safely used in the outpatient parenteral antimicrobial therapy (OPAT) setting?Mycoses. 2019 Mar;62(3):196-203. doi: 10.1111/myc.12874. Epub 2019 Jan 22. Mycoses. 2019. PMID: 30499620 Review.
-
Outpatient Parenteral Antimicrobial Therapy in Children.Curr Infect Dis Rep. 2019 Apr 16;21(5):17. doi: 10.1007/s11908-019-0669-6. Curr Infect Dis Rep. 2019. PMID: 30993447 Review.
Cited by
-
Quantitative analysis of the impact of infectious disease physicians on patients in the emergency department fast-track parenteral antibiotics program.BMC Infect Dis. 2024 Jul 1;24(1):655. doi: 10.1186/s12879-024-09305-0. BMC Infect Dis. 2024. PMID: 38956481 Free PMC article.
-
A case series of infectious complications in medical tourists requiring hospital admission or outpatient home parenteral therapy.J Assoc Med Microbiol Infect Dis Can. 2022 Feb 24;7(1):64-74. doi: 10.3138/jammi-2021-0015. eCollection 2022 Mar. J Assoc Med Microbiol Infect Dis Can. 2022. PMID: 36340853 Free PMC article.
-
Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: A retrospective cohort study.Antimicrob Steward Healthc Epidemiol. 2022 Nov 11;2(1):e183. doi: 10.1017/ash.2022.313. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36406163 Free PMC article.
-
Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review.Drugs. 2023 Jul;83(11):967-983. doi: 10.1007/s40265-023-01893-6. Epub 2023 Jun 14. Drugs. 2023. PMID: 37314633 Review.
-
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy.Pharmaceutics. 2023 Nov 30;15(12):2705. doi: 10.3390/pharmaceutics15122705. Pharmaceutics. 2023. PMID: 38140046 Free PMC article.
References
-
- Nathwani D. The management of skin and soft tissue infections: Outpatient parenteral antibiotic therapy in the United Kingdom. Chemotherapy. 2001;47(Suppl 1):17–23. - PubMed
-
- Chambers S, Gallagher K, Metcalf S, Pithie A. Home intravenous antimicrobial service – twelve months experience in Christchurch. N Z Med J. 2002;115:216–8. - PubMed
-
- Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: A retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents. 2012;39:407–13. - PubMed
-
- Bazaz R, Chapman AL, Winstanley TG. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms. J Antimicrob Chemother. 2010;65:1510–3. - PubMed
-
- Bernard L, El H, Pron B, et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: Evaluation of efficacy, tolerance and cost. J Clin Pharm Ther. 2001;26:445–51. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources